Literature DB >> 27381075

Current management of the gastrointestinal complications of systemic sclerosis.

Anton Emmanuel1.   

Abstract

Systemic sclerosis is a multisystem autoimmune disorder that involves the gastrointestinal tract in more than 90% of patients. This involvement can extend from the mouth to the anus, with the oesophagus and anorectum most frequently affected. Gut complications result in a plethora of presentations that impair oral intake and faecal continence and, consequently, have an adverse effect on patient quality of life, resulting in referral to gastroenterologists. The cornerstones of gastrointestinal symptom management are to optimize symptom relief and monitor for complications, in particular anaemia and malabsorption. Early intervention in patients who develop these complications is critical to minimize disease progression and improve prognosis. In the future, enhanced therapeutic strategies should be developed, based on an ever-improving understanding of the intestinal pathophysiology of systemic sclerosis. This Review describes the most commonly occurring clinical scenarios of gastrointestinal involvement in patients with systemic sclerosis as they present to the gastroenterologist, with recommendations for the suggested assessment protocol and therapy in each situation.

Entities:  

Mesh:

Year:  2016        PMID: 27381075     DOI: 10.1038/nrgastro.2016.99

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  19 in total

Review 1.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

2.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

3.  Pain threshold and temporomandibular function in systemic sclerosis: comparison with psoriatic arthritis.

Authors:  Antonino Lo Giudice; Idona Brewer; Rosalia Leonardi; Neal Roberts; Gianluca Bagnato
Journal:  Clin Rheumatol       Date:  2018-02-14       Impact factor: 2.980

4.  Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches.

Authors:  Anna-Maria Hoffmann-Vold; Elizabeth R Volkmann
Journal:  J Scleroderma Relat Disord       Date:  2019-12-20

Review 5.  Small intestinal bacterial overgrowth in systemic sclerosis.

Authors:  Kathleen Morrisroe; Murray Baron; Tracy Frech; Mandana Nikpour
Journal:  J Scleroderma Relat Disord       Date:  2019-07-29

Review 6.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

7.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

8.  Combination therapy for systemic sclerosis-associated pneumatosis intestinalis.

Authors:  Kanyada Koysombat; Maria Vittoria Capanna; Nina Stafford; Tim Orchard
Journal:  BMJ Case Rep       Date:  2018-07-11

Review 9.  A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.

Authors:  Shannon Teaw; Monique Hinchcliff; Michelle Cheng
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

10.  Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model.

Authors:  Jungen Tang; Xin Zhou; Xuefen Wu; Shengyan Lin; Bingxia Ming; Jixin Zhong; Baoju Wang; Lingli Dong
Journal:  Front Cell Infect Microbiol       Date:  2021-05-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.